US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist

10.140
-0.100-0.98%

Close Nov 22 16:00 ET

10.210
+0.070+0.69%

Post 19:50 ET

1.19BMarket Cap-6071P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

21.13%-34.69M

32.14%-45.12M

60.67%-31.6M

4.14%-247.06M

20.86%-56.24M

35.03%-43.98M

-7.27%-66.49M

-41.02%-80.34M

-47.58%-257.72M

-37.43%-71.07M

Net income from continuing operations

7.21%-41.54M

26.28%-52.33M

55.83%-35.38M

15.83%-262.14M

7.96%-66.28M

58.44%-44.77M

-5.32%-70.99M

-24.53%-80.1M

-50.93%-311.46M

-0.97%-72.02M

Operating gains losses

--226K

---112K

---543K

--849K

----

Depreciation and amortization

270.03%1.43M

-9.07%351K

-1.38%358K

62.85%1.52M

10.95%385K

37.23%387K

149.03%386K

142.00%363K

105.73%934K

155.15%347K

Other non cash items

-18.43%903K

1.28%1.11M

1.85%1.1M

-86.52%4.39M

1.09%1.11M

-96.37%1.11M

129.89%1.09M

129.51%1.08M

10,435.60%32.56M

1,364.00%1.1M

Change In working capital

58.56%-3.8M

25.48%-4.27M

39.57%-5.44M

-130.97%-23.5M

105.54%411K

-844.53%-9.18M

-60.30%-5.73M

-2,029.08%-9.01M

-381.08%-10.18M

-157.76%-7.41M

-Change in receivables

-651.54%-16.61M

-16.65%-5.18M

-163.21%-11.35M

-105.12%-17.35M

-6.02%-6.39M

9.09%-2.21M

---4.44M

---4.31M

---8.46M

---6.03M

-Change in inventory

117.77%611K

67.08%-633K

89.10%-113K

25.21%-5.62M

124.29%779K

20.15%-3.44M

---1.92M

---1.04M

---7.51M

---3.21M

-Change in prepaid assets

50.53%-4.25M

-335.50%-2.17M

329.32%5.54M

-348.30%-8.62M

24.98%1.47M

-3,680.42%-8.59M

-55.27%921K

---2.42M

147.37%3.47M

196.62%1.17M

-Change in payables and accrued expense

218.16%16.63M

3,291.80%3.89M

160.94%660K

217.11%8.75M

491.98%4.72M

-33.32%5.23M

97.80%-122K

-222.32%-1.08M

-74.24%2.76M

-94.33%798K

-Change in other current liabilities

-12.12%-185K

-10.98%-182K

-12.50%-180K

-51.73%-657K

-12.00%-168K

-52.78%-165K

-86.36%-164K

-83.91%-160K

-278.19%-433K

-552.17%-150K

Cash from discontinued investing activities

Operating cash flow

21.13%-34.69M

32.14%-45.12M

60.67%-31.6M

4.14%-247.06M

20.86%-56.24M

35.03%-43.98M

-7.27%-66.49M

-41.02%-80.34M

-47.58%-257.72M

-37.43%-71.07M

Investing cash flow

Cash flow from continuing investing activities

86.12%84.78M

-169.72%-62.14M

-126.63%-28.7M

306.69%180.23M

-247.36%-62.19M

123.09%45.55M

69.54%89.12M

604.39%107.75M

-14.81%-87.2M

79.59%42.2M

Net PPE purchase and sale

-123.44%-143K

--0

-28.53%-428K

95.12%-6K

-966.67%-64K

-245.00%-276K

33.87%-82K

66.53%-333K

52.87%-123K

Net intangibles purchase and sale

----

--0

----

---22.95M

--0

Net investment purchase and sale

86.17%84.92M

-169.51%-62.14M

-126.61%-28.7M

382.65%180.66M

-246.91%-62.18M

126.17%45.61M

69.81%89.39M

599.26%107.83M

14.73%-63.92M

78.13%42.32M

Cash from discontinued investing activities

Investing cash flow

86.12%84.78M

-169.72%-62.14M

-126.63%-28.7M

306.69%180.23M

-247.36%-62.19M

123.09%45.55M

69.54%89.12M

604.39%107.75M

-14.81%-87.2M

79.59%42.2M

Financing cash flow

Cash flow from continuing financing activities

-54.56%394K

36.36%1.46M

161,664.00%161.76M

-66.43%101.32M

10,221.10%99.29M

-99.70%867K

-5.66%1.07M

-99.32%100K

7.04%301.8M

-98.68%962K

Net issuance payments of debt

----

--0

----

68.95%125M

--0

Net common stock issuance

--0

--161.68M

-43.82%98.9M

--98.9M

--0

-15.15%176.05M

--0

Proceeds from stock option exercised by employees

-54.56%394K

36.36%1.46M

-18.00%82K

-17.56%2.42M

-59.67%388K

48.46%867K

-5.66%1.07M

-61.69%100K

39.44%2.94M

81.17%962K

Net other financing activities

----

-33.60%-2.19M

--0

Cash from discontinued financing activities

Financing cash flow

-54.56%394K

36.36%1.46M

161,664.00%161.76M

-66.43%101.32M

10,221.10%99.29M

-99.70%867K

-5.66%1.07M

-99.32%100K

7.04%301.8M

-98.68%962K

Net cash flow

Beginning cash position

-19.95%84.89M

131.65%190.71M

62.78%89.32M

-44.00%54.88M

30.95%108.4M

69.00%106.04M

15.91%82.33M

-44.00%54.88M

47.08%97.99M

55.25%82.78M

Current changes in cash

1,975.78%50.48M

-546.42%-105.8M

268.87%101.46M

180.01%34.5M

31.40%-19.14M

-87.86%2.43M

386.09%23.7M

202.02%27.51M

-237.46%-43.12M

-162.46%-27.9M

Effect of exchange rate changes

230.67%98K

-388.89%-26K

-40.38%-73K

---50K

--68K

---75K

--9K

---52K

--0

End cash Position

24.98%135.47M

-19.95%84.89M

131.65%190.71M

62.78%89.32M

30.95%108.4M

69.00%106.04M

15.91%82.33M

-44.00%54.88M

Free cash flow

20.92%-34.83M

32.42%-45.12M

60.71%-31.6M

11.93%-247.49M

20.98%-56.25M

51.41%-44.05M

-7.57%-66.76M

-40.85%-80.43M

-60.00%-281M

-36.98%-71.19M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	21.13%-34.69M	32.14%-45.12M	60.67%-31.6M	4.14%-247.06M	20.86%-56.24M	35.03%-43.98M	-7.27%-66.49M	-41.02%-80.34M	-47.58%-257.72M	-37.43%-71.07M
Net income from continuing operations	7.21%-41.54M	26.28%-52.33M	55.83%-35.38M	15.83%-262.14M	7.96%-66.28M	58.44%-44.77M	-5.32%-70.99M	-24.53%-80.1M	-50.93%-311.46M	-0.97%-72.02M
Operating gains losses	--226K	---112K	---543K	--849K	----	----	----	----	----	----
Depreciation and amortization	270.03%1.43M	-9.07%351K	-1.38%358K	62.85%1.52M	10.95%385K	37.23%387K	149.03%386K	142.00%363K	105.73%934K	155.15%347K
Other non cash items	-18.43%903K	1.28%1.11M	1.85%1.1M	-86.52%4.39M	1.09%1.11M	-96.37%1.11M	129.89%1.09M	129.51%1.08M	10,435.60%32.56M	1,364.00%1.1M
Change In working capital	58.56%-3.8M	25.48%-4.27M	39.57%-5.44M	-130.97%-23.5M	105.54%411K	-844.53%-9.18M	-60.30%-5.73M	-2,029.08%-9.01M	-381.08%-10.18M	-157.76%-7.41M
-Change in receivables	-651.54%-16.61M	-16.65%-5.18M	-163.21%-11.35M	-105.12%-17.35M	-6.02%-6.39M	9.09%-2.21M	---4.44M	---4.31M	---8.46M	---6.03M
-Change in inventory	117.77%611K	67.08%-633K	89.10%-113K	25.21%-5.62M	124.29%779K	20.15%-3.44M	---1.92M	---1.04M	---7.51M	---3.21M
-Change in prepaid assets	50.53%-4.25M	-335.50%-2.17M	329.32%5.54M	-348.30%-8.62M	24.98%1.47M	-3,680.42%-8.59M	-55.27%921K	---2.42M	147.37%3.47M	196.62%1.17M
-Change in payables and accrued expense	218.16%16.63M	3,291.80%3.89M	160.94%660K	217.11%8.75M	491.98%4.72M	-33.32%5.23M	97.80%-122K	-222.32%-1.08M	-74.24%2.76M	-94.33%798K
-Change in other current liabilities	-12.12%-185K	-10.98%-182K	-12.50%-180K	-51.73%-657K	-12.00%-168K	-52.78%-165K	-86.36%-164K	-83.91%-160K	-278.19%-433K	-552.17%-150K
Cash from discontinued investing activities
Operating cash flow	21.13%-34.69M	32.14%-45.12M	60.67%-31.6M	4.14%-247.06M	20.86%-56.24M	35.03%-43.98M	-7.27%-66.49M	-41.02%-80.34M	-47.58%-257.72M	-37.43%-71.07M
Investing cash flow
Cash flow from continuing investing activities	86.12%84.78M	-169.72%-62.14M	-126.63%-28.7M	306.69%180.23M	-247.36%-62.19M	123.09%45.55M	69.54%89.12M	604.39%107.75M	-14.81%-87.2M	79.59%42.2M
Net PPE purchase and sale	-123.44%-143K	--0	--0	-28.53%-428K	95.12%-6K	-966.67%-64K	-245.00%-276K	33.87%-82K	66.53%-333K	52.87%-123K
Net intangibles purchase and sale	----	----	----	--0	----	----	----	----	---22.95M	--0
Net investment purchase and sale	86.17%84.92M	-169.51%-62.14M	-126.61%-28.7M	382.65%180.66M	-246.91%-62.18M	126.17%45.61M	69.81%89.39M	599.26%107.83M	14.73%-63.92M	78.13%42.32M
Cash from discontinued investing activities
Investing cash flow	86.12%84.78M	-169.72%-62.14M	-126.63%-28.7M	306.69%180.23M	-247.36%-62.19M	123.09%45.55M	69.54%89.12M	604.39%107.75M	-14.81%-87.2M	79.59%42.2M
Financing cash flow
Cash flow from continuing financing activities	-54.56%394K	36.36%1.46M	161,664.00%161.76M	-66.43%101.32M	10,221.10%99.29M	-99.70%867K	-5.66%1.07M	-99.32%100K	7.04%301.8M	-98.68%962K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	68.95%125M	--0
Net common stock issuance	--0	--0	--161.68M	-43.82%98.9M	--98.9M	--0	--0	--0	-15.15%176.05M	--0
Proceeds from stock option exercised by employees	-54.56%394K	36.36%1.46M	-18.00%82K	-17.56%2.42M	-59.67%388K	48.46%867K	-5.66%1.07M	-61.69%100K	39.44%2.94M	81.17%962K
Net other financing activities	----	----	----	----	----	----	----	----	-33.60%-2.19M	--0
Cash from discontinued financing activities
Financing cash flow	-54.56%394K	36.36%1.46M	161,664.00%161.76M	-66.43%101.32M	10,221.10%99.29M	-99.70%867K	-5.66%1.07M	-99.32%100K	7.04%301.8M	-98.68%962K
Net cash flow
Beginning cash position	-19.95%84.89M	131.65%190.71M	62.78%89.32M	-44.00%54.88M	30.95%108.4M	69.00%106.04M	15.91%82.33M	-44.00%54.88M	47.08%97.99M	55.25%82.78M
Current changes in cash	1,975.78%50.48M	-546.42%-105.8M	268.87%101.46M	180.01%34.5M	31.40%-19.14M	-87.86%2.43M	386.09%23.7M	202.02%27.51M	-237.46%-43.12M	-162.46%-27.9M
Effect of exchange rate changes	230.67%98K	-388.89%-26K	-40.38%-73K	---50K	--68K	---75K	--9K	---52K	--0	--0
End cash Position	24.98%135.47M	-19.95%84.89M	131.65%190.71M	62.78%89.32M	62.78%89.32M	30.95%108.4M	69.00%106.04M	15.91%82.33M	-44.00%54.88M	-44.00%54.88M
Free cash flow	20.92%-34.83M	32.42%-45.12M	60.71%-31.6M	11.93%-247.49M	20.98%-56.25M	51.41%-44.05M	-7.57%-66.76M	-40.85%-80.43M	-60.00%-281M	-36.98%-71.19M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data